dazmegrel has been researched along with 6-ketoprostaglandin f1 alpha in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (82.76) | 18.7374 |
| 1990's | 4 (13.79) | 18.2507 |
| 2000's | 1 (3.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloch, KJ; Hoaglin, DC; Morel, DR; Robinson, DR; Skoskiewicz, M; Zapol, WM | 1 |
| Aramburo, MJ; Hammerman, C; Hill, V | 1 |
| Himmelstein, SI; Klotman, PE | 1 |
| Demling, RH; LaLonde, C | 1 |
| Chen, P; Raj, JU | 1 |
| Apprill, P; Ashton, J; Buja, LM; Campbell, WB; Raheja, S; Schmitz, JM; Tilton, G; Willerson, JT | 1 |
| Hammerman, C; Komar, K; Meadow, W; Strates, E | 1 |
| Hardee, GE; Hardee, MM; Moore, JN | 2 |
| Ghai, R; Lindsay, LA; Olson, RW; Sakane, Y; Smith, EF | 1 |
| Brigham, KL; Ogletree, ML; Snapper, JR | 1 |
| Clement, RE; Fiallo, V; Fink, MP; Gardiner, WM; Morrissey, PE; Stein, KL | 1 |
| Angus, JA; Crabb, DJ; Knight, KR; Martin, TJ; Niall, M; O'Brien, BM | 1 |
| Moore, JN; Semrad, SD | 1 |
| Peskar, BA; Scheid, P; Shams, H | 1 |
| Helmchen, U; Kudelka, S; Stahl, RA | 1 |
| Cattell, V; Cook, HT; Moncada, S; Salmon, JA; Smith, J | 1 |
| Bjøro, K; Hovig, T; Stokke, KT; Stray-Pedersen, S | 1 |
| Brigham, KL; Butka, BJ; Newman, JH | 1 |
| Beck, S; Brown, CB; Fox, M; Gibbons, CP; Lindsey, NJ; Preston, FE; Raftery, AT; Slater, DN; Wiley, KN | 1 |
| Anner, H; Hechtman, HB; Kaufman, RP; Kobzik, L; Shepro, D; Valeri, CR | 1 |
| Carpenter, LJ; Roth, RA | 1 |
| Bennett, A; Carroll, MA; Corrigan, CJ; Melhuish, PB; Patel, S; Stamford, IF | 1 |
| Zipser, RD | 1 |
| Bernutz, C; Böhlig, B; Fischer, S; Struppler, M; Weber, PC; Wober, W | 1 |
| Li, JX; Lu, CY; Oliver, JR; Philips, JB | 1 |
| Grantham, KD; Gray, BM; Li, JX; Oliver, JR; Philips, JB; Pritchard, DG | 1 |
| Ahmed, Y; Elder, MG; Sullivan, MH | 1 |
| Arikawa, E; Galipeau, D; McNeill, JH; Sekirov, I | 1 |
2 trial(s) available for dazmegrel and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Effects of selective inhibition of thromboxane synthesis on renal function in humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Double-Blind Method; Glomerular Filtration Rate; Humans; Imidazoles; Inulin; Kidney; Male; Oxidoreductases; p-Aminohippuric Acid; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1985 |
The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Blood Platelets; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Imidazoles; Male; Middle Aged; Oxidoreductases; Random Allocation; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1983 |
27 other study(ies) available for dazmegrel and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Leukotrienes, thromboxane A2, and prostaglandins during systemic anaphylaxis in sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Anaphylaxis; Animals; Blood Pressure; Chromones; Cyclooxygenase Inhibitors; Dinitrophenols; Female; Histamine Release; Imidazoles; Leukotriene E4; Leukotrienes; Lung; Lymph; Male; Meclofenamic Acid; Prostaglandins; Pulmonary Circulation; Serum Albumin, Bovine; Sheep; SRS-A; Stroke Volume; Thromboxane B2; Thromboxane-A Synthase; Time Factors; Vascular Resistance | 1991 |
Lipoxygenase and cyclooxygenase blockade by BW755C does not prevent the secondary phase of septic pulmonary hypertension.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cyclooxygenase Inhibitors; Heart Rate; Hemodynamics; Hypertension, Pulmonary; Imidazoles; Lipoxygenase Inhibitors; Pyrazoles; Swine; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 1989 |
The role of thromboxane in two-kidney, one-clip Goldblatt hypertension in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Biphenyl Compounds; Blood Pressure; Glomerular Filtration Rate; Heptanoic Acids; Hypertension, Renovascular; Imidazoles; Kidney; Male; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Reference Values; Regional Blood Flow; Renal Circulation; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1989 |
Inhibition of thromboxane synthetase accentuates hemodynamic instability and burn edema in the anesthetized sheep model.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Flow Velocity; Blood Volume; Burns; Cardiac Output; Disease Models, Animal; Edema; Hemodynamics; Imidazoles; Lymph; Oxygen Consumption; Sheep; Skin Diseases; Thromboxane-A Synthase; Vascular Resistance; Vasodilation | 1989 |
Role of eicosanoids in hypoxic vasoconstriction in isolated lamb lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Chromones; Epoprostenol; Hypoxia; Imidazoles; In Vitro Techniques; Indomethacin; Lipoxygenase; Lung; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pulmonary Circulation; Receptors, Leukotriene; Receptors, Prostaglandin; Sheep; SRS-A; Thromboxane B2; Thromboxanes; Vasoconstriction | 1987 |
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic alpha-Antagonists; Animals; Arteriosclerosis; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Imidazoles; Male; Platelet Activating Factor; Platelet Aggregation; Serotonin Antagonists; Thromboxane B2 | 1985 |
Selective inhibition of thromboxane synthetase reduces group-B-beta-hemolytic-streptococci-induced pulmonary hypertension in piglets.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Animals, Newborn; Epoprostenol; Hypertension, Pulmonary; Imidazoles; Radioimmunoassay; Streptococcal Infections; Swine; Thromboxane B2; Thromboxane-A Synthase | 1988 |
Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Clonixin; Endotoxins; Escherichia coli; Horses; Imidazoles; Lactates; Male; Nicotinic Acids; Phenylbutazone; Thromboxane B2; Thromboxane-A Synthase | 1986 |
Dazoxiben, UK 38,485 and aspirin: duration of effect for preventing thrombotic sudden death in rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Imidazoles; Male; Rabbits; Thrombocytopenia; Thrombosis; Thromboxane B2; Time Factors | 1986 |
Direct and indirect effects of leukotriene D4 on the lungs of unanesthetized sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Anesthesia; Animals; Arachidonate 5-Lipoxygenase; Blood Pressure; Female; Hypertension, Pulmonary; Ibuprofen; Imidazoles; Lung; Lung Compliance; Lymph; Male; Meclofenamic Acid; Prostaglandin-Endoperoxide Synthases; Pulmonary Wedge Pressure; Sheep; SRS-A; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cyclooxygenase Inhibitors; Disease Models, Animal; Endotoxins; Escherichia coli; Hemodynamics; Imidazoles; Indomethacin; Lipopolysaccharides; Male; Prostaglandins; Rabbits; Shock, Septic; Thromboxane A2; Thromboxane-A Synthase | 1988 |
Pharmacologic modification of blood flow in the rabbit microvasculature with prostacyclin and related drugs.
Topics: 6-Ketoprostaglandin F1 alpha; Abdominal Muscles; Animals; Blood Flow Velocity; Blood Pressure; Cyclooxygenase Inhibitors; Epoprostenol; Imidazoles; Indomethacin; Microcirculation; Platelet Aggregation; Pyrazoles; Pyrazolones; Rabbits; Regional Blood Flow; Surgical Flaps; Thromboxane-A Synthase; Vasoconstriction; Vasodilation | 1985 |
Effects of a specific thromboxane synthetase inhibitor in equine endotoxaemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Endotoxins; Escherichia coli; Female; Horses; Imidazoles; Male; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Acid infusion elicits thromboxane A2-mediated effects on respiration and pulmonary hemodynamics in the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Cats; Female; Hydrochloric Acid; Imidazoles; Infusions, Intravenous; Male; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Respiration; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1988 |
High protein intake stimulates glomerular prostaglandin formation in remnant kidneys.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Body Weight; Dietary Proteins; Dinoprostone; Imidazoles; Indomethacin; Inulin; Kidney Glomerulus; Organ Size; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Thromboxane B2 | 1987 |
Effect of a thromboxane synthetase inhibitor on eicosanoid synthesis and glomerular injury during acute unilateral glomerulonephritis in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprostone; Glomerulonephritis; Imidazoles; Kidney Glomerulus; Prostaglandins E; Radioimmunoassay; Rats; Rats, Inbred Lew; Thromboxane B2; Thromboxane-A Synthase | 1986 |
Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Clonixin; Epoprostenol; Horses; Imidazoles; Male; Nicotinic Acids; Orchiectomy; Phenylbutazone; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1986 |
Formation of prostanoids in human umbilical vessels perfused in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Dinoprost; Dinoprostone; Humans; Imidazoles; Immunologic Techniques; In Vitro Techniques; Indomethacin; Prostaglandins; Prostaglandins E; Prostaglandins F; Radioimmunoassay; Thromboxane B2; Umbilical Arteries; Umbilical Veins | 1986 |
Thromboxane A2 and prostacyclin do not modulate pulmonary hemodynamics during exercise in sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Cardiac Output; Epoprostenol; Hemodynamics; Hypoxia; Ibuprofen; Imidazoles; Lung; Lymph; Meclofenamic Acid; Physical Exertion; Pulmonary Artery; Sheep; Thromboxane A2; Vascular Resistance | 1986 |
Cortical and vascular prostaglandin synthesis during renal allograft rejection in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Blood Vessels; Creatinine; Graft Rejection; Imidazoles; Indomethacin; Kidney; Kidney Cortex; Kidney Transplantation; Prostaglandins; Rats; Rats, Inbred Strains; Thromboxane B2 | 1987 |
A high plasma prostaglandin to thromboxane ratio protects against renal ischemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Creatinine; Evaluation Studies as Topic; Ibuprofen; Imidazoles; Ischemia; Kidney; Kidney Tubular Necrosis, Acute; Male; Methacrylates; Pyridines; Rats; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Involvement of thromboxane in injury to isolated rat lungs perfused with phorbol myristate acetate in the presence and absence of neutrophils.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Imidazoles; Indomethacin; Lung; Male; Neutrophils; Organ Size; Perfusion; Pressure; Pulmonary Edema; Rats; Rats, Inbred Strains; Tetradecanoylphorbol Acetate; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Survival of mice with NC carcinoma is unchanged by drugs that are thought to inhibit thromboxane synthesis or increase prostacyclin formation.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antineoplastic Agents; Female; Imidazoles; Mammary Neoplasms, Experimental; Mice; Prostaglandins E; Pyrazoles; Pyrazolones; Thromboxane B2; Thromboxane-A Synthase | 1986 |
Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Endotoxins; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Imidazoles; Leukotriene Antagonists; Leukotrienes; Lipoxygenase; Masoprocol; Pentoxifylline; Sepsis; Swine; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Toxemia; Tumor Necrosis Factor-alpha | 1995 |
Capsular type-specific polysaccharide partially inhibits group B Streptococcus-induced pulmonary hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Bacterial Capsules; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Hypertension, Pulmonary; Imidazoles; Polysaccharides, Bacterial; Streptococcal Infections; Streptococcus agalactiae; Swine; Thromboxane B2; Thromboxane-A Synthase | 1993 |
Effects of a thromboxane synthetase inhibitor on platelet function; possible risks of use in pregnancy.
Topics: 6-Ketoprostaglandin F1 alpha; Blood Platelets; Cells, Cultured; Collagen; Contraindications; Dinoprostone; Eicosanoids; Female; Humans; Imidazoles; Platelet Aggregation; Pregnancy; Thromboxane B2; Thromboxane-A Synthase | 1993 |
Chronic thromboxane synthase inhibition prevents fructose-induced hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Blood Glucose; Blood Pressure; Enzyme Inhibitors; Epoprostenol; Fructose; Hypertension; Imidazoles; Insulin; Rats; Rats, Wistar; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes; Triglycerides | 2001 |